BioClinica is launching its new Trident IVR/IWR platform, to provide a cheaper, quicker way to set up, monitor and maintain randomisation and supplies in clinical trials.
The CDMO Althea Technologies has extended its pre-filled syringe manufacturing capabilities with a new INOVA H3-5 high speed syringe filling line, which will be available for production in Q1 2011.
Eli Lilly has unveiled plans to close its Singapore R&D centre by the end of the year and relocate discovery operations to its global headquarters in the US.
ShangPharma has raised $87m through an IPO on the New York Stock Exchange according to a Bloomberg report, beating the $46m to $53m the Chinese CRO forecast.
Southern Research Institute is acquiring BioCryst Pharmaceuticals’ bioanalytical laboratory assets and personnel in a move towards expanding its bioanalytical service offerings.
Cell Biosciences plans to gain ground in the protein-based drugs market by acquiring Convergent Bioscience at the end of October for a cash sum of $12m (€8.6m.)
Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.
A week of global anti-counterfeiting law enforcement coordinated by Interpol led to the shutdown of 290 websites, seizure of 11,000 packages and confiscation of 1m pills.
SGS Life Sciences will roll out new biologics testing capabilities across its network in bid to be the world’s number one contract biopharmaceuticals testing laboratory by 2014.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at AMRI, Novella Clinical, BioClinica and Idis.
Drug delivery and pharmaceutical coating technologies firm SurModics will cut jobs and reorganise operations in a bid to reverse falling revenues and tumbling profits.
Beta-Pro is addressing rising demands from drug discovery and research institutes in the hepatocyte market by expanding its site at the University of Virginia Research Park, US, with a new GLP facility.
Covance has forged a new deal with InPhoton to provide clients with access to intravital microscopy imaging technology to address drug discovery and development questions across the preclinical space.
A strategic partnership between New England IRB (NEIRB) and Veritas IRB of Montreal will see their clients following a common protocol review for studies they conduct throughout the US and Canada.
IDT Biologika.says demand for vaccines in emerging markets is big chance for Big Pharma and hence a growing niche for contractors with the technical capabilities to carry out such work.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including board elections at ISPE and appointments at Advaxis and Asubio.
BioFocus has sealed two compound management deals with the National Cancer Institute and eMolecules, while extending its relationship with Chiesi Farmaceutici for $3.5m (€2.5m).
Charles River Laboratories (CRL) has added two new exclusive knockout rats to its preclinical development offering in deal with Transposagen Biopharmaceuticals.
The FDA is to collaborate with the WHO to build a global surveillance and monitoring system for combating falsified medicines and breaches of the supply chain.
“Musty smells” associated with three Lipitor bottles indicate a problem within the supply chain, says Rexam of Las Piedras, Puerto Rico, who were confirmed by Pfizer as the “third-party recalling supplier.”
Pharmatek Laboratories has once again expanded service offerings at its San Diego, California facility by adding two roller compactors to its solid oral dosage form manufacturing capabilities.
IMS Health predicts that global drug sales will increase 5 to 7 per cent next year, driven by development of innovative pharmaceuticals and growth of emerging markets.
Easily translatable and adaptable simplified clinical research ethic training guidelines have been created to support field workers in low-resource settings.
Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates.
Oracle Health Sciences has strengthened its clinical trial analytics offering to reduce start up times and offer greater insight into screening, recruitment and retention.
Guy Villax, board member of the EFCG, talks falsified APIs, EU efforts to tackle the issue, and the presence of gangsters in the pharma industry in an in-PharmaTechnologist video interview.
Novartis will use technology from Synthetics Genomics Vaccines to speed up the development of influenza vaccines for seasonal and pandemic flu outbreaks.
Wipro Technologies has introduced Rapid Trials to provide clients with a data collection platform that can be deployed quickly and with minimal infrastructure investment.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Aurobindo, DPT, Ricerca and Datatrak.